164 related articles for article (PubMed ID: 25326863)
1. SATB1 is an independent prognostic factor in radically resected upper gastrointestinal tract adenocarcinoma.
Hedner C; Gaber A; Korkocic D; Nodin B; Uhlén M; Kuteeva E; Johannesson H; Jirström K; Eberhard J
Virchows Arch; 2014 Dec; 465(6):649-59. PubMed ID: 25326863
[TBL] [Abstract][Full Text] [Related]
2. SATB1 is an independent prognostic marker for gastric cancer in a Chinese population.
Lu X; Cheng C; Zhu S; Yang Y; Zheng L; Wang G; Shu X; Wu K; Liu K; Tong Q
Oncol Rep; 2010 Oct; 24(4):981-7. PubMed ID: 20811679
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and treatment predictive significance of SATB1 and SATB2 expression in pancreatic and periampullary adenocarcinoma.
Elebro J; Heby M; Gaber A; Nodin B; Jonsson L; Fristedt R; Uhlén M; Jirström K; Eberhard J
J Transl Med; 2014 Oct; 12():289. PubMed ID: 25323550
[TBL] [Abstract][Full Text] [Related]
4. Loss of special AT-rich sequence-binding protein 1 (SATB1) predicts poor survival in patients with colorectal cancer.
Al-Sohaily S; Henderson C; Selinger C; Pangon L; Segelov E; Kohonen-Corish MR; Warusavitarne J
Histopathology; 2014 Aug; 65(2):155-63. PubMed ID: 24118100
[TBL] [Abstract][Full Text] [Related]
5. Expression and Prognostic Significance of Human Epidermal Growth Factor Receptors 1 and 3 in Gastric and Esophageal Adenocarcinoma.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
PLoS One; 2016; 11(2):e0148101. PubMed ID: 26844548
[TBL] [Abstract][Full Text] [Related]
6. Expression and prognostic significance of the polymeric immunoglobulin receptor in esophageal and gastric adenocarcinoma.
Fristedt R; Gaber A; Hedner C; Nodin B; Uhlén M; Eberhard J; Jirström K
J Transl Med; 2014 Apr; 12():83. PubMed ID: 24694107
[TBL] [Abstract][Full Text] [Related]
7. Pilot study special AT-rich sequence-binding protein 1 investigating as a potential biomarker for esophageal squamous cell carcinoma.
Cong QX; Zhang H; Sun SX; Li HF; Wang Y; Jian S
Dis Esophagus; 2016 Aug; 29(6):621-6. PubMed ID: 25951709
[TBL] [Abstract][Full Text] [Related]
8. HLA-DR expression in tumor epithelium is an independent prognostic indicator in esophageal adenocarcinoma patients.
Dunne MR; Michielsen AJ; O'Sullivan KE; Cathcart MC; Feighery R; Doyle B; Watson JA; O'Farrell NJ; Ravi N; Kay E; Reynolds JV; Ryan EJ; O'Sullivan J
Cancer Immunol Immunother; 2017 Jul; 66(7):841-850. PubMed ID: 28315927
[TBL] [Abstract][Full Text] [Related]
9. Prognostic implications of
Knief J; Reddemann K; Lazar-Karsten P; Herhahn T; Petrova E; Wellner U; Thorns C
J Clin Pathol; 2017 Mar; 70(3):274-276. PubMed ID: 28011578
[No Abstract] [Full Text] [Related]
10. Molecular correlates and prognostic significance of SATB1 expression in colorectal cancer.
Nodin B; Johannesson H; Wangefjord S; O'Connor DP; Lindquist KE; Uhlén M; Jirström K; Eberhard J
Diagn Pathol; 2012 Aug; 7():115. PubMed ID: 22935204
[TBL] [Abstract][Full Text] [Related]
11. Mucin 16 (cancer antigen 125) expression in human tissues and cell lines and correlation with clinical outcome in adenocarcinomas of the pancreas, esophagus, stomach, and colon.
Streppel MM; Vincent A; Mukherjee R; Campbell NR; Chen SH; Konstantopoulos K; Goggins MG; Van Seuningen I; Maitra A; Montgomery EA
Hum Pathol; 2012 Oct; 43(10):1755-63. PubMed ID: 22542127
[TBL] [Abstract][Full Text] [Related]
12. Is intestinal metaplasia a necessary precursor lesion for adenocarcinomas of the distal esophagus, gastroesophageal junction and gastric cardia?
Chandrasoma P; Wickramasinghe K; Ma Y; DeMeester T
Dis Esophagus; 2007; 20(1):36-41. PubMed ID: 17227308
[TBL] [Abstract][Full Text] [Related]
13. PLCE1 mRNA and protein expression and survival of patients with esophageal squamous cell carcinoma and gastric adenocarcinoma.
Li WQ; Hu N; Burton VH; Yang HH; Su H; Conway CM; Wang L; Wang C; Ding T; Xu Y; Giffen C; Abnet CC; Goldstein AM; Hewitt SM; Taylor PR
Cancer Epidemiol Biomarkers Prev; 2014 Aug; 23(8):1579-1588. PubMed ID: 24867265
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological study of early adenocarcinoma of the gastric cardia: comparison with early adenocarcinoma of the distal stomach and esophagus.
Tajima Y; Nakanishi Y; Yoshino T; Kokawa A; Kusano M; Shimoda T
Oncology; 2001; 61(1):1-9. PubMed ID: 11474241
[TBL] [Abstract][Full Text] [Related]
15. Expression of SATB1 and heparanase in gastric cancer and its relationship to clinicopathologic features.
Cheng C; Lu X; Wang G; Zheng L; Shu X; Zhu S; Liu K; Wu K; Tong Q
APMIS; 2010 Nov; 118(11):855-63. PubMed ID: 20955458
[TBL] [Abstract][Full Text] [Related]
16. Expression and prognostic significance of human epidermal growth factor receptors 1, 2 and 3 in oesophageal and gastric adenocarcinomas preneoadjuvant and postneoadjuvant treatment.
Hedner C; Borg D; Nodin B; Karnevi E; Jirström K; Eberhard J
J Clin Pathol; 2018 May; 71(5):451-462. PubMed ID: 29138285
[TBL] [Abstract][Full Text] [Related]
17. Smad4 loss in esophageal adenocarcinoma is associated with an increased propensity for disease recurrence and poor survival.
Singhi AD; Foxwell TJ; Nason K; Cressman KL; McGrath KM; Sun W; Bahary N; Zeh HJ; Levy RM; Luketich JD; Davison JM
Am J Surg Pathol; 2015 Apr; 39(4):487-95. PubMed ID: 25634752
[TBL] [Abstract][Full Text] [Related]
18. High Expression of Cathepsin E in Tissues but Not Blood of Patients with Barrett's Esophagus and Adenocarcinoma.
Fisher OM; Levert-Mignon AJ; Lord SJ; Botelho NK; Freeman AK; Thomas ML; Falkenback D; Wettstein A; Whiteman DC; Bobryshev YV; Lord RV
Ann Surg Oncol; 2015 Jul; 22(7):2431-8. PubMed ID: 25348778
[TBL] [Abstract][Full Text] [Related]
19. Loss of special AT-rich binding protein 1 expression is a marker of poor survival in lung cancer.
Selinger CI; Cooper WA; Al-Sohaily S; Mladenova DN; Pangon L; Kennedy CW; McCaughan BC; Stirzaker C; Kohonen-Corish MR
J Thorac Oncol; 2011 Jul; 6(7):1179-89. PubMed ID: 21597389
[TBL] [Abstract][Full Text] [Related]
20. Risk of malignant progression in Barrett's esophagus patients: results from a large population-based study.
Bhat S; Coleman HG; Yousef F; Johnston BT; McManus DT; Gavin AT; Murray LJ
J Natl Cancer Inst; 2011 Jul; 103(13):1049-57. PubMed ID: 21680910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
